
04.07.2025 • News
Hikma Invests $1 Billion to Expand US Generics Manufacturing
Hikma Pharmaceuticals USA announces $1 billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines.
Hikma Pharmaceuticals USA announces $1 billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines.